✕
Login
Register
EN
Translate page
EN
English
ES
Español
FR
Français
DE
Deutsch
ZH
中文
AR
العربية
PT
Português
RU
Русский
JA
日本語
KO
한국어
HI
हिन्दी
IT
Italiano
Back to News
FDA Approves Pfizer And BioNTech's Supplemental Biologics License Application For 2026-2027 COVID-19 Vaccine Formula
Benzinga Newsdesk
www.benzinga.com
Positive 76.0%
Neg 0%
Neu 0%
Pos 76%
2026-2027 COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating variants
Shipping will begin immediately to ensure rapid access to this season’s vaccine
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment